Summit Trail Advisors’s QuidelOrtho QDEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.36M Buy
82,484
+1,470
+2% +$36.1K 0.02% 783
2025
Q4
$2.31M Sell
81,014
-424
-0.5% -$11.5K 0.04% 328
2025
Q3
$2.4M Buy
81,438
+67,903
+502% +$1.86M 0.03% 351
2025
Q2
$390K Buy
+13,535
New +$400K 0.01% 819
2024
Q4
Sell
-5,272
Closed -$240K 677
2024
Q3
$240K Buy
+5,272
New +$213K 0.01% 617

Other funds holding QDEL

Summit Trail Advisors's QDEL Position: Q1 2026 in Review

Summit Trail Advisors increased its QuidelOrtho (QDEL) stake by 1.8% in Q1 2026, buying an estimated $36.1K and bringing the position to 82,484 shares worth $1.36M. The position accounts for 0.02% of the portfolio, ranked #783.

Summit Trail Advisors first reported a position in QDEL in Q3 2024 and has held it in 5 quarters since. The position peaked at $2.4M in Q3 2025. 237 funds tracked by Wall St. Rank hold QDEL as of Q1 2026.

  • Summit Trail Advisors held 82,484 shares of QuidelOrtho worth $1.36M as of Q1 2026.
  • Summit Trail Advisors bought 1,470 QuidelOrtho shares in Q1 2026, an estimated $36.1K.
  • QuidelOrtho made up 0.02% of Summit Trail Advisors's portfolio in Q1 2026, its #783 holding.
  • Summit Trail Advisors first reported a position in QuidelOrtho in Q3 2024 and has held it in 5 quarters since.
  • Summit Trail Advisors's QuidelOrtho position peaked at $2.4M in Q3 2025.
  • 237 funds tracked by Wall St. Rank held QuidelOrtho as of Q1 2026.

Based on Summit Trail Advisors's 13F filing for Q1 2026, filed 12 May 2026.